Wave Life Sciences

Wave Life Sciences

WVE· Manufacturing· Fiscal year ends in December

CEO pay in FY2022Stock +122.9% in FY2022

Paul B. Bolno is the CEO of Wave Life Sciences and was paid $2.7M in FY2022 (Dec).

Pay$100 in the stock at the end of FY21 → $223
CEO pay is from each Wave Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Paul B. BolnoFY2022
  2. 2Kyle Moran, CFAFY2024
  3. 3Christopher Francis, Ph.D.FY2023
  4. 4Chandra Vargeese, Ph.D.FY2022

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Wave Life Sciences paid its one named executive on file $1.9M in FY2024 (Dec).

Name
Kyle Moran, CFAChief Financial Officer
Paul B. BolnoPresident and Chief Executive OfficerNot disclosedNot disclosed
Christopher Francis, Ph.D.Senior Vice President, Corporate Development and Head of Emerging AreasNot disclosed
Chandra Vargeese, Ph.D.Chief Technology Officer, Head of Platform Discovery SciencesNot disclosedNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers15

See all

The FY2024 (Dec) proxy of Wave Life Sciences names 15 peer companies for pay. Among Wave Life Sciences and these peers, CEO pay was the lowest of 7 and total shareholder return was the highest of 7.

7th highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by CEO pay:

$4.3M$15.4M

1st highest of 7in Wave Life Sciences and its pay peers, FY2024 (Dec) by total shareholder return:

$58$157

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Christian HenryChair · 8 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive

The board of the latest proxy (FY2024).

Shared directors

Activity

Filings6

See all
Proxy statementDEF 14AMay 7, 2026—
Annual report10-KFeb 26, 2026FY2025
Proxy statementDEF 14AJun 23, 2025FY2024
Annual report10-KMar 4, 2025FY2024
Proxy statementDEF 14AJun 21, 2024FY2023
Annual report10-KMar 6, 2024FY2023